Oncogenicity of LHX4 in colorectal cancer through Wnt/β-catenin/TCF4 cascade

Tumor Biology - Tập 35 Số 10 - Trang 10319-10324 - 2014
Nier Cha1, Wei Liu2, Na Yang3, Shengzhi Xie4, Yumei Gao5, Xia Chen6, Xiaoli Wang1, Jun Ren1
1Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Hangfangdian, Haidian District, Beijing, 100038, People’s Republic of China
2Department of Radiotherapy, Inner Mongolia People’s Hospital, Hohhot, Inner Mongolia, 010017, People’s Republic of China
3General Hospital of Chinese People’s Armed Police Forces, South Builing NO.2 Division, Beijing, 100039, China
4Department of Oncology, General Hospital of Chinese People’s Armed Police Forces, Beijing, 100039, China
5Department of Surgical Oncology, Inner Mongolia People’s Hospital, Hohhot, Inner Mongolia, 010017, People’s Republic of China
6Inner Mongolia Red Cross Blood Center, Hohhot, Inner Mongolia, 010010, People’s Republic of China

Tóm tắt

Từ khóa


Tài liệu tham khảo

Perencevich M, Stoffel EM. A multidisciplinary approach to the diagnosis and management of multiple colorectal polyps. Gastroenterol Hepatol. 2011;7:420.

Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol Mech Dis. 2011;6:479–507.

Gerstung M, Eriksson N, Lin J, Vogelstein B, Beerenwinkel N. The temporal order of genetic and pathway alterations in tumorigenesis. PLoS One. 2011;6:e27136.

Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073–87. e2073.

Thompson MD, Monga SP. WNT/beta-catenin signaling in liver health and disease. Hepatology. 2007;45:1298–305.

Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8:387–98.

Pevny LH, Lovell-Badge R. < i> Sox</i>genes find their feet. Curr Opin Genet Dev. 1997;7:338–44.

Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn. 2010;239:56–68.

Kiefer JC. Back to basics: sox genes. Dev Dyn. 2007;236:2356–66.

Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004;6:497–506.

Liu F, Millar SE. Wnt/beta-catenin signaling in oral tissue development and disease. J Dent Res. 2010;89:318–30.

Franklin MC, Carey KD, Vajdos FF, Leahy DJ, de Vos AM, Sliwkowski MX. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell. 2004;5:317–28.

Agus DB, Akita RW, Fox WD, Lewis GD, Higgins B, Pisacane PI, et al. Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth. Cancer Cell. 2002;2:127–37.

Muthuswamy SK, Gilman M, Brugge JS. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol Cell Biol. 1999;19:6845–57.